A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Cited by (999)

Items 701–800 of 999

1. Impact of Subtended Myocardial Mass Assessed by Coronary Computed Tomographic Angiography-Based Myocardial Segmentation
   Soo‐Jin Kang, Young‐Hak Kim, June‐Goo Lee, Do‐Yoon Kang, Pil Hyung Lee, Jung‐Min Ahn, Duk‐Woo Park, Seung‐Whan Lee, Cheol Whan Lee, Seong‐Wook Park et al. · 2018 · The American Journal of Cardiology
2. Association between serum phosphorus and subclinical coronary atherosclerosis in asymptomatic Korean individuals without kidney dysfunction
   Kyung Sun Park, Yong Jik Lee, Gyung‐Min Park, Jongha Park, Yong‐Giun Kim, Dong Hyun Yang, Joon‐Won Kang, Tae‐Hwan Lim, Hong‐Kyu Kim, Jaewon Choe et al. · 2020 · American Journal of Clinical Nutrition
3. Coronary Computed Tomography Angiography Compared With Single Photon Emission Computed Tomography Myocardial Perfusion Imaging as a Guide to Optimal Medical Therapy in Patients Presenting With Stable Angina: The RESCUE Trial
   Arthur E. Stillman, Constantine A. Gatsonis, João A.C. Lima, Tao Liu, Bradley S. Snyder, Jean B. Cormack, Vinay Malholtra, Mitchell D. Schnall, James E. Udelson, Udo Hoffmann et al. · 2020 · Journal of the American Heart Association
4. Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis
   Jingxing Liu, Xinhua Hu · 2022 · Diabetes and Vascular Disease Research
5. Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA Trial
   Shun Kohsaka, Kentaro Ejiri, Hidenobu Takagi, Ippei Watanabe, Yodo Gatate, Kenji Fukushima, Shintaro Nakano, Taishi Hirai · 2023 · JACC Asia
6. Myocardial Ischemia: A Silent Epidemic in Type 2 Diabetes Patients
   Claude Le Feuvre, Sophie Jacqueminet, Olivier Barthélémy · 2011 · Future Cardiology
7. Resting Heart Rate and Metabolic Syndrome in Patients With Diabetes and Coronary Artery Disease in Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
   Jamal S. Rana, Regina M. Hardison, Rodica Pop‐Busui, Maria M. Brooks, Teresa L.Z. Jones, Richard W. Nesto, Martial G. Bourassa, on behalf of the BARI 2D Investigators · 2010 · Preventive Cardiology
8. Simple Integer Risk Score to Determine Prognosis of Patients With Hypertension and Chronic Stable Coronary Artery Disease
   Anthony A. Bavry, Dharam J. Kumbhani, Yan Gong, Eileen Mary Handberg, Rhonda M. Cooper‐DeHoff, Carl J. Pepine · 2013 · Journal of the American Heart Association
9. New Insights in the Diagnosis and Treatment of Heart Failure
   Giulio Agnetti, Massimo Francesco Piepoli, Giuseppe Siniscalchi, Francesco Nicolini · 2015 · BioMed Research International
10. Ischemic Heart Disease in Women
    Kellan E. Ashley, Stephen A. Geraci · 2013 · Southern Medical Journal
11. Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial
    Abdulla A. Damluji, Erin R. Cohen, Mauro M. Moscucci, Robert J. Myerburg, Mauricio G. Cohen, Maria M. Brooks, Michael W. Rich, Daniel E. Forman · 2017 · International Journal of Cardiology
12. Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment
    Sai Tian, Jing Han, Rong Huang, Jie Lena Sun, Rongrong Cai, Yanjue Shen, Shaohua Wang · 2017 · Journal of Alzheimer s Disease
13. The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease
    Wassim Mosleh, Abhinav Sharma, Mandeep S. Sidhu, Brian J. Page, Umesh C. Sharma, Michael E. Farkouh · 2017 · Cardiovascular Drugs and Therapy
14. INTERNATIONAL JOURNAL OF INTERVENTIONAL CARDIOANGIOLOGY
    2023 · Международный журнал интервенционной кардиоангиологии
15. Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics
    G. P. Arutyunov, Sergey Anatol'evich Boytsov, M. I. Voyevoda, Victor S. Gurevich, Oksana M. Drapkina, Valery V. Kukharchuk, Martynov Ai, I. V. Sergiyenko, Marina Vladimirovna Shestakova, A. S. Aliyeva et al. · 2019 · Rational Pharmacotherapy in Cardiology
16. Understanding the Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Paradox
    Jennifer B. Green · 2014 · Postgraduate Medicine
17. Comparative effectiveness of coronary artery bypass grafting (CABG) surgery and percutaneous coronary intervention (PCI) in elderly patients with diabetes
    Ruchit Shah, Yi Yang, John P. Bentley, Benjamin F. Banahan · 2016 · Current Medical Research and Opinion
18. Trends in Ischemic Evaluation in New-Onset Heart Failure Without Known Coronary Artery Disease
    Charlotte Andersson, Morten Schou, William E. Boden, Brian Schwartz, Jacob Joseph, Emil Loldrup Fosbøl, Lars Køber, Gunnar Gislason, Christian Tobias Torp-Pedersen · 2022 · JACC Heart Failure
19. The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease
    Michael Khorsandi, Roger Scott Blumenthal, Michael Joseph Blaha, Payal Kohli · 2024 · Clinical Cardiology
20. Strategies for chronic coronary disease: A brief guide for clinicians
    Chayakrit Krittanawong, Muzamil Khawaja, Hafeez Ul Hassan Virk, Johao Escobar, Umair Khalid, Yochai Birnbaum, Carl J. Lavie, Samin Kumar Sharma, Hani M. Jneid, Sunil V. Rao et al. · 2024 · npj Cardiovascular Health
21. The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: A meta-analysis
    Yulan Zhao, Xuelian He, Chengjin M. Huang, Xiaonan Fu, Xuegui Shi, Ying Wu, Yijie Han, Naishi Li, Yanxiang Wu, Chew‐Kiat Heng · 2010 · Diabetes Research and Clinical Practice
22. Impact of different exercise training modalities on the coronary collateral circulation and plaque composition in patients with significant coronary artery disease (EXCITE trial): study protocol for a randomized controlled trial
    Madlen Uhlemann, Volker Adams, Karsten Lenk, Axel Linke, Sandra Erbs, Jennifer Adam, Hölger Thiele, Thomas Hilberg, Matthias Gutberlet, Martin F. Grunze et al. · 2012 · Trials
23. Medical Management and Strategies to Prevent Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus
    Mae Sheikh‐Ali, Prafull Raheja, Nancy Borja‐Hart · 2013 · Postgraduate Medicine
24. Towards evidence-based percutaneous coronary intervention: The Rene Laennec lecture in clinical cardiology
    Patrick A. Calvert, Philippe Gabríel Steg · 2012 · European Heart Journal
25. Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study)
    Larry A. Weinrauch, John A. D’Elia, Peter V. Finn, Eldrin Foster Lewis, Akshay Suvas Desai, Brian Lee Claggett, Mark Emmanuel Cooper, Janet B. McGill · 2016 · Diabetes Research and Clinical Practice
26. Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery
    Ricky D. Turgeon, Sheri L. Koshman, Erik R. E. Youngson, Glen J. Pearson · 2019 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
27. Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis
    Alexandre Leszek, Lauriane Poli, Stéphanie Zbinden, Lucas C. Godoy, Jean‐Luc Reny, Michael E. Farkouh, David M. Charytan, Thomas A. Mavrakanas · 2022 · Atherosclerosis
28. Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D
    Joel Zonszein, Manuel Lombardero, Faramarz Ismail‐Beigi, Pasquale J Palumbo, Suzy Foucher, Yolanda Groenewoud, Gary W. Cushing, BERNARDO LEO WAJCHENBERG, SAUL M. GENUTH, BARI 2D Study Group · 2015 · Journal of Diabetes Research
29. Impact of Metabolic Syndrome on Subclinical Atherosclerosis in Asymptomatic Individuals
    Gyung-Min Park, Hyonggin An, Seung‐Whan Lee, Young–Rak Cho, Eun Ha Gil, Sung‐Ho Her, Hyun Woo Park, Jung‐Min Ahn, Duk‐Woo Park, Soo-Jin Kang et al. · 2015 · Circulation Journal
30. Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention?
    Seung‐Jung Park, Jung‐Min Ahn · 2012 · Current Opinion in Cardiology
31. Relationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetes
    Cornelis J. Roos, Roxana Djaberi, Joanne Désirée Schuijf, Eelco J.P. de Koning, Ton J. Rabelink, Johannes W. A. Smit, Alberto M. Pereira, Imad Al Younis, Bernies van der Hiel, Arthur J.H.A. Scholte et al. · 2011 · European Journal of Nuclear Medicine and Molecular Imaging
32. Race/Ethnic Disparities in Risk Factor Control and Survival in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
    Nirat Beohar, Veronica V. Sansing, Andrew Mark Davis, VANKEEPURAM S. SRINIVAS, Tarek A. Helmy, Andrew D. Althouse, Stephen B. Thomas, Maria M. Brooks · 2013 · The American Journal of Cardiology
33. Glucose lowering and cardiovascular disease: what do we know and what should we do?
    ALICE Y.Y. CHENG, Lawrence A. Leiter · 2010 · European Journal of Cardiovascular Prevention & Rehabilitation
34. Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization
    Yedid Elbez, Adrian Cheong, Amir-Ali Fassa, Eric A. Cohen, Christopher Michael Reid, Rūta Marija Babarskienė, Deepak L. Bhatt, Philippe Gabríel Steg · 2015 · European Heart Journal - Quality of Care and Clinical Outcomes
35. Coronary revascularization vs. medical therapy following coronary-computed tomographic angiography in patients with low-, intermediate- and high-risk coronary artery disease: results from the CONFIRM long-term registry
    Joshua Schulman‐Marcus, Fay Yu-Huei Lin, Heidi Gransar, Daniel S. Berman, Tracy Q. Callister, Augustin J. DeLago, Martin Hadamitzky, Jörg Hausleiter, Mouaz Husayn Al-Mallah, Matthew Jay Budoff et al. · 2017 · European Heart Journal - Cardiovascular Imaging
36. Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes
    Mary T. Korytkowski, Daniel E. Forman · 2017 · Diabetes Care
37. Prognosis of CT-derived Fractional Flow Reserve in the Prediction of Clinical Outcomes
    Charis McNabney, Stephanie Sellers, Ryan J. A. Wilson, Shmuel Hart, Samuel Rosenblatt, Darra T. Murphy, Philipp Blanke, Amir Ali Ahmadi, Jaydeep Halankar, Adrian Attinger‐Toller et al. · 2019 · Radiology Cardiothoracic Imaging
38. Health economics-based verification of functional myocardial ischemia evaluation of stable coronary artery disease in Japan: A long-term longitudinal study using propensity score matching
    Tomoyuki Takura, Hiroyoshi Yokoi, Nobuhiro Tanaka, Naoya Matsumoto, Eri Yoshida, Tomoaki Nakata · 2021 · Journal of Nuclear Cardiology
39. Long term outcomes of percutaneous coronary intervention vs coronary artery bypass grafting in patients with diabetes mellitus with multi vessels diseases: A meta-analysis
    Vikash Jaiswal, Yasar Sattar, Song Peng Ang, Angela Ishak, Sidra Naz, YUSRA MINAHIL NASIR, David Day Song, Anoop Titus, Helen Ye Rim Huang, Gaurav Kumar Chaudhary et al. · 2023 · IJC Heart & Vasculature
40. Racial Disparities in Diagnostic Evaluation and Revascularization in Patients With Acute Myocardial Infarction—A 15-Year Longitudinal Study
    Muddasir Ashraf, Viviana Zlochiver, Sulaiman Sajed, Saaniyah Sajed, TANVIR K. BAJWA, Suhail Q. Allaqaband, Muhammad Fuad Jan · 2023 · Current Problems in Cardiology
41. Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease.
    G. Giustino, G. Dangas · 2015 · Progress in cardiovascular diseases
42. Six‐year prognosis of diabetic patients with coronary artery disease
    Savina Nodari, Alessandra Manerba, Alberto Vaccari, Giuseppe Milesi, Valentina Carubelli, Valentina Lazzarini, Carlo Lombardi, Federica Ettori, Marco Metra, Alessandra Dei · 2011 · European Journal of Clinical Investigation
43. Association of Dysglycemia and All-Cause Mortality Across the Spectrum of Coronary Artery Disease
    Shiwei Yang, Yujie Zhou, Xiao-Fang Tian, Guozhong Pan, Yuyang Liu, Jian Zhang, Zhenfeng Guo, Shuyan Chen, Songtao Gao, Jie Du et al. · 2013 · Mayo Clinic Proceedings
44. Noninvasive Stress Testing for Coronary Artery Disease
    Todd D. Miller, John Wells Askew, Nandan Sadanand Anavekar · 2015 · Heart Failure Clinics
45. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging
    Kameel Kassab, Kifah Hussain, Andrea Torres, Fady Iskander, Mina Iskander, Rozi Khan, Rami Doukky · 2020 · Journal of Nuclear Cardiology
46. Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome
    Ana Gabaldón-Pérez, Víctor Marcos‐Garcés, José Gavara, César Ríos‐Navarro, Gema Miñana, Antoni Bayés‐Genís, Oliver Hüsser, Juan Manuel Sanchís, Julio E. Núñez, F. Javier Chorro et al. · 2021 · Journal of Clinical Medicine
47. Use of a Continuous Glucose Monitoring System in High-Risk Hospitalized Noncritically Ill Patients With Diabetes After Cardiac Surgery and During Their Transition of Care From the Intensive Care Unit During COVID-19: A Pilot Study
    Ann T. Sweeney, Samara Pena, Jeena Sandeep, Bryan Hernandez, Ye Chen, Janis L. Breeze, Aysegul Bulut, Karen Feghali, Moaz Abdelrehim, Mohamed Abdelazeem et al. · 2022 · Endocrine Practice
48. Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A Meta-Analysis
    Ibadete Bytyçi, Defrim Morina, Sefer Bytyqi, Gani Bajraktari, Michael Y. Henein · 2023 · Journal of Clinical Medicine
49. Pediatric Lipid Management
    J. Zachariah, Philip K. Johnson · 2014 · Endocrinology and metabolism clinics of North America (Print)
50. Asymptomatic coronary artery disease in type II diabetes.
    Paramdeep S. Baweja, Pratik B. Sandesara, M Javed Ashraf · 2014 · Europe PMC (PubMed Central)
51. Initial Strategy of Revascularization Versus Optimal Medical Therapy for Improving Outcomes in Ischemic Heart Disease: A Review of the Literature
    A. Vincent Songco, Sorin J. Brener · 2012 · Current Cardiology Reports
52. The resting status of the coronary microcirculation is a predictor of microcirculatory function following elective PCI for stable angina
    Jamie John Layland, Chris Judkins, Sonny C. Palmer, Rob Whitbourn, Amy L Wilson-O'Brien, Andrew MacIsaac, Andrew Wilson · 2013 · International Journal of Cardiology
53. Tree-based identification of subgroups for time-varying covariate survival data
    Marnie H. Bertolet, Maria M. Brooks, Vera Bittner · 2012 · Statistical Methods in Medical Research
54. Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial
    Ariane Drouin, Nicolas Noiseux, Carl Chartrand‐Lefebvre, Gilles Soulez, Samer Mansour, Jan-Alexis Tremblay, Fadi Basile, Ignacio Prieto, Louis‐Mathieu Stevens · 2013 · Trials
55. Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology
    Luca Sgarra, Francesco Addabbo, Maria Assunta Potenza, Monica Montagnani · 2012 · American Journal of Physiology-Endocrinology and Metabolism
56. Antianginal medications and long‐term outcomes after elective catheterization in patients with coronary artery disease
    Lan Shen, John Paul Vavalle, Samuel Broderick, Linda K. Shaw, Pamela S. Douglas · 2016 · Clinical Cardiology
57. Comprehensive plaque assessment with serial coronary CT angiography: translation to bedside
    Suvasini Lakshmanan, Vahid Rezvanizadeh, Matthew Jay Budoff · 2020 · International journal of cardiac imaging
58. Outcomes of patients with moderate-to-severe Ischemia excluded from the ischemia trial
    Mouaz Husayn Al-Mallah, Ahmed Ibrahim Ahmed, Faisal Nabi, Su Min Chang, Neal S. Kleiman, Mohammed A. Chamsi‐Pasha, Alpesh R. Shah, Yuishi Han, William A. Zoghbi, John J. Mahmarian · 2021 · Journal of Nuclear Cardiology
59. Revascularization or medical therapy for stable coronary artery disease patients with different degrees of ischemia: a systematic review and meta-analysis of the role of myocardial perfusion
    Jingwen Yong, Jinfan Tian, Xin Zhao, Xueyao Yang, Mingduo Zhang, Yuan Zhou, Yi He, Xiantao Song · 2022 · Therapeutic Advances in Chronic Disease
60. Ischemia burden on stress SPECT MPI predicts long-term outcomes after revascularization in stable coronary artery disease
    Hendrik J. Boiten, Jan C. van den Berge, Roelf Valkema, Ron T. van Domburg, Felix Zijlstra, Arend F. L. Schinkel · 2016 · Journal of Nuclear Cardiology
61. Alpha-crystallin: an ATP-independent complete molecular chaperone toward sorbitol dehydrogenase
    Isabella Marini, Roberta Moschini, Antonella DEL CORSO, Umberto Mura · 2005 · Cellular and Molecular Life Sciences
62. Percutaneous Coronary Intervention, Diabetes Mellitus, and Death
    Harold L. Dauerman · 2010 · Journal of the American College of Cardiology
63. Applicability of the COURAGE, BARI 2D, and FREEDOM Trials to Contemporary Practice
    Sripal Bangalore · 2016 · Journal of the American College of Cardiology
64. Correction of hypertriglyceridemia in order to reduce the residual risk in atherosclerosis-related diseases. Expert Council Opinion
    G. P. Arutyunov, Sergey Anatol'evich Boytsov, Mikhail Ivanovich Voevoda, Oksana M. Drapkina, Valery V. Kukharchuk, Martynov Ai, Marina Vladimirovna Shestakova, Victor S. Gurevich, И. В. Сергиенко, Asiiat S. Alieva et al. · 2019 · Russian Journal of Cardiology
65. Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility
    William E. Boden, Raffaele De Caterina, David Paul Taggart · 2021 · European Heart Journal
66. Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
    Charles Joseph Ferro, Miriam Berry, William Edward Moody, Sudhakar George, Adnan Sharif, John Townend · 2021 · Clinical Kidney Journal
67. Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods Study
    Dan D. Nguyen, Carole Decker, Christina M. Pacheco, Stacy L. Farr, Christine Fuss, Ruth Masterson Creber, Stephanie Pena, Nobuhiro Ikemura, Anezi I. Uzendu, David Joel Maron et al. · 2024 · Circulation Cardiovascular Quality and Outcomes
68. Cardiovascular Disease and Oral Agent Glucose-Lowering Therapies in the Management of Type 2 Diabetes
    Philip Home · 2012 · Diabetes Technology & Therapeutics
69. Evidence-Based Management of Stable Ischemic Heart Disease
    Sripal Bangalore, David Joel Maron, Judith S. Hochman · 2015 · JAMA
70. Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)
    Victor M.G. Legrand, Scot Garg, Patrick W.J.C. Serruys, Kari S. Virtanen, Günter Szurawitzki, Vassilis A. Voudris, Alessandro Fontanelli, Knut Endersen, Igor Kranjec, Tessa Rademaker et al. · 2011 · EuroIntervention
71. Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia
    Ki Hong Choi, Joo Myung Lee, Il Park, Jihoon Kim, Tae‐Min Rhee, Doyeon Hwang, Jonghanne Park, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song et al. · 2018 · International Journal of Cardiology
72. The Year in Atherothrombosis
    Javier Sanz, Pedro Moreno, Valentı́n Fuster · 2010 · Journal of the American College of Cardiology
73. The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients
    Emmanuel Cosson, Minh Tuan Nguyen, B. Chanu, Şevket Balta, K. Takbou, Paul Elie Valensi · 2012 · Nutrition Metabolism and Cardiovascular Diseases
74. Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT)
    Christopher B. Overgaard, Vladimír Džavík, Christopher E.H. Buller, Li Liu, Waldemar Banasiak, Gerard Patrick Devlin, Aldo Pietro Maggioni, Jonathan Leor, J. R. Burton, Gilmar Reis et al. · 2013 · International Journal of Cardiology
75. Correlation between single nucleotide polymorphisms of the ACTA2 gene and coronary artery stenosis in patients with type 2 diabetes mellitus
    HUI FANG, Xiaoli Luo, Yan Wang, Nian Liu, Chunjiang Fu, Hongyong Wang, Yuqiang Fang, Weibin Shi, Ye Zhang, Chunyu Zeng et al. · 2014 · Experimental and Therapeutic Medicine
76. An Aggregate Biomarker Risk Score Predicts High Risk of Near‐Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
    Nima Ghasemzadeh, Maria M. Brooks, Helen Aslanidou Vlachos, Regina M. Hardison, Sergey Sikora, Laurence S. Sperling, Arshed Ali Quyyumi, Stephen E. Epstein · 2017 · Journal of the American Heart Association
77. The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
    Rabea Asleh, Mohammad Sheikh‐Ahmad, Αlexandros Briasoulis, Sudhir S. Kushwaha · 2017 · Heart Failure Reviews
78. Advances in Management of Stable Coronary Artery Disease: the Role of Revascularization?
    Konstantinos V. Voudris, Clifford J. Kavinsky · 2019 · Current Treatment Options in Cardiovascular Medicine
79. The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
    Botey Katamu Benjamin, Chunguang Qiu, Zhanying Han, Wenjie Lu, Guoju Sun, Xiaofei Qin, Xule Wang, Xi Wang, Ran Li, Liang Pan · 2021 · Journal of Diabetes Research
80. Voor elke huisartsenpraktijk
    Wim A M Lucassen · 2010 · Huisarts en Wetenschap
81. Ischemia Dictates Outcome, Not Symptoms
    Peter Howard Stone · 2013 · Journal of the American College of Cardiology
82. Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation
    Ana Duarte, Alexis Llewellyn, Ruth Walker, Laetitia Helene Marie Schmitt, Kath E. Wright, Simon Walker, Claire Rothery, Mark C. Simmonds · 2021 · Health Technology Assessment
83. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study
    Thiago Luis Scudeler, Michael E. Farkouh, Whady Armindo Hueb, Paulo Cury Rezende, Alessandro Gonçalves Campolina, Eduardo Bello Martins, Lucas C. Godoy, Paulo Rogério Soares, José Antônio Franchini Ramires, Roberto Kalil Filho · 2022 · BMJ Open
84. Integrated myocardial flow reserve (iMFR) assessment: diffuse atherosclerosis and microvascular dysfunction are more strongly associated with mortality than focally impaired perfusion
    Jonathan B. Moody, Alexis Poitrasson-Rivière, Jennifer M. Renaud, Tomoe Hagio, Mouaz Husayn Al-Mallah, Richard Lawrence Weinberg, Edward P. Ficaro, Venkatesh Locharla Murthy · 2023 · European Journal of Nuclear Medicine and Molecular Imaging
85. Antagonist molecules in the treatment of angina
    Ashish K Gupta, David E. Winchester, Carl J. Pepine · 2013 · Expert Opinion on Pharmacotherapy
86. Management of the Patient With Diabetes and Coronary Artery Disease: A Contemporary Review
    Timothy E. Raymond, Russell E. Raymond, Abraham Michael Lincoff · 2013 · Future Cardiology
87. Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center
    Jarosław P. Wasilewski, Lech Poloński, Andrzej Lekston, Tadeusz Osadnik, Rafał Reguła, Kamil Bujak, Anna Kurek · 2015 · Trials
88. Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: Results from the DIAD study
    Suman Tandon, Frans J.Th. Wackers, Silvio E. Inzucchi, Shanti Bansal, Lawrence H. Staib, Deborah Ann Chyun, Janice A. Davey, Lawrence H. Young, for the DIAD Investigators · 2012 · Diabetes and Vascular Disease Research
89. Myocardial Imaging Should Not Exclude Patients With Ischemic Heart Failure From Coronary Revascularization
    Eric J. Velazquez · 2012 · Circulation Cardiovascular Imaging
90. Long-term studies of treatments for type 2 diabetes
    Augusto Enrique Caballero · 2016 · Postgraduate Medicine
91. Contemporary Chest Pain Evaluation: The Australian Case for Cardiac CT
    Abdul Rahman Ihdayhid, Nick S.R. Lan, Gemma A. Figtree, Sanjay Patel, Clare Gabrielle Arnott, Christian R Hamilton-Craig, Peter James Psaltis, Jonathon A Leipsic, Timothy A. Fairbairn, Sudhir Wahi et al. · 2023 · Heart Lung and Circulation
92. Impact of Coronary CT Angiography–derived Fractional Flow Reserve on Downstream Management and Clinical Outcomes in Individuals with and without Diabetes
    Gaurav Singh Gulsin, Γεώργιος Τζίμας, Kenneth-Royce Holmes, Hidenobu Takagi, Stephanie Sellers, Philipp Blanke, Lynne Koweek, Bjarne Linde Nørgaard, Jesper Jensen, Mark Rabbat et al. · 2023 · Radiology Cardiothoracic Imaging
93. Is Ischemia Dead After STICH?
    Raymond J. Gibbons, Todd D. Miller · 2013 · Journal of the American College of Cardiology
94. Screening Asymptomatic Patients with Type 2 Diabetes Mellitus for Coronary Artery Disease: Does It Improve Patient Outcome?
    Jamshid Shirani, Vasken Dilsizian · 2010 · Current Cardiology Reports
95. Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies
    Pamela B. DeGuzman, Kwame Osei Akosah, Allan G. Simpson, Kirk E Barbieri, Gregory C Megginson, Randal I. Goldberg, George Beller · 2012 · Diabetes and Vascular Disease Research
96. A Randomized, Double-Blind, Placebo-Controlled, Crossover, Dose-Ranging Multicenter Study to Determine the Effect of Sublingual Nitroglycerin Spray on Exercise Capacity in Patients with Chronic Stable Angina
    Udho Thadani, Thomas Wittig · 2012 · Clinical Medicine Insights Cardiology
97. Treatment of specific macrovascular beds in patients with diabetes mellitus
    Allison M Petznick, Jay H. Shubrook · 2010 · Osteopathic Medicine and Primary Care
98. Clinical usefulness and cost effectiveness of fractional flow reserve among Indian patients (FIND study)
    G. Sengottuvelu, Babu Chakravarthy, Ravindran Rajendran, Sreyes Ravi · 2014 · Catheterization and Cardiovascular Interventions
99. ACCF/AHA Practice Guideline 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter et al. · 2011
100. Diabetes and the Cardiovascular System
     Darren K. McGuire · 2012 · Elsevier eBooks